Skip to main content
Premium Trial:

Request an Annual Quote

MDS' Q1 Revenues Rise 23 Percent

NEW YORK (GenomeWeb News) – MDS today said that its first-quarter revenues rose 23 percent as sales from Molecular Devices exceeded the firm’s expectations.

For the three-month period ended Jan. 31, MDS reported revenues of $296 million, up from $241 million in the first quarter of 2007.

Molecular Devices, which was acquired in the second quarter of 2007 and is part of the MDS Analytical Technologies unit, brought in first-quarter revenues of $56 million, its highest quarter to date, according to MDS. Overall, that unit had revenue of $116 million, up 119 percent year over year. Sciex contributed $60 million in revenue for the quarter.

MDS Pharma Services’ revenues decreased 1 percent to $120 million from $121 million in the same period of 2007, with slight growth in late-stage net revenues being offset by a decline in early-stage net revenues, the Toronto-based firm said.

MDS Nordion’s revenues were down 10 percent to $60 million from $67 million, due primarily to a medical isotope supply disruption and lower cobalt shipments, according to the company.

Currency effects increased net revenue in the first quarter of 2008 compared to the first quarter of 2007 by approximately $25 million.

MDS posted a first-quarter profit of $17 million, or $.14 per share, compared to $16 million, or $.11 per share, in the first quarter of 2007.

The firm’s SG&A costs increased 18.5 percent to $64 million from $54 million year over year. Its R&D expenses rose 67 percent to $20 million from $12 million, due to higher spending in the MDA Analytical Services unit.

MDS finished the first quarter with $144 million in cash and cash equivalents.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.